|
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
|
[X] |
|
QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE |
|
OR |
||
|
[ ] |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE |
|
For the transition period from ____________________ to ____________________ |
||
(Commission File Number) 0-30270
|
|
|
CROMPTON CORPORATION |
|
(Exact name of registrant as specified in its charter) |
|
Delaware |
52-2183153 |
||||||||
|
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) |
||||||||
|
199 Benson Road, Middlebury, Connecticut |
|
||||||||
|
(Address of principal executive offices) |
(Zip Code) |
||||||||
|
|
|
|
|||||||
|
(203) 573- 2000 (Registrant's telephone number, including area code) |
|||||||||
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. |
|||||||||
|
[X] |
Yes |
|
[ ] |
No |
|||||
|
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). |
|||||||||
|
[X] |
Yes |
|
[ ] |
No |
|||||
|
The number of shares of common stock outstanding as of the latest practicable date, is as follows: |
|||||||||
|
Class |
Outstanding at March 31, 2005
|
||||||||
CROMPTON CORPORATION AND SUBSIDIARIES
FORM 10-Q
FOR THE QUARTER ENDED MARCH 31, 2005
|
|
|
|
|
INDEX |
PAGE |
|
|
PART I. |
FINANCIAL INFORMATION |
|
|
Item 1. |
Financial Statements and Accompanying Notes
|
|
|
Condensed Consolidated Statements of Earnings (Unaudited) - First quarter ended March 31, 2005 and 2004 |
2 |
|
|
Condensed Consolidated Balance Sheets - March 31, 2005 (Unaudited) and December 31, 2004 |
3 |
|
|
Condensed Consolidated Statements of Cash Flows (Unaudited) - First quarter ended March 31, 2005 and 2004 |
4 |
|
|
Notes to Condensed Consolidated Financial Statements (Unaudited) |
5 |
|
|
Review Report of Independent Registered Public Accounting Firm |
22 |
|
|
Item 2. |
Management's Discussion and Analysis of Financial Condition and Results of Operations |
23 |
|
Item 3. |
Quantitative and Qualitative Disclosures about Market Risk |
33 |
|
Item 4. |
Controls and Procedures |
34 |
|
PART II. |
OTHER INFORMATION |
|
|
Item 1. |
Legal Proceedings |
35 |
|
Item 4. |
Submission of Matters to a Vote of Security Holders |
44 |
|
Item 6. |
Exhibits |
45 |
|
Signatures |
46 |
-1-
PART I. FINANCIAL INFORMATION
ITEM 1. Financial Statements and Accompanying Notes
CROMPTON CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Earnings (Unaudited)
First quarter ended March 31, 2005 and 2004
(In thousands of dollars, except per share data)
|
2005 |
2004 |
||||
|
Net sales |
$ |
589,730 |
$ |
555,509 |
|
|
Cost of products sold |
418,669 |
430,988 |
|||
|
Selling, general and administrative |
61,271 |
71,321 |
|||
|
Depreciation and amortization |
30,126 |
28,880 |
|||
|
Research and development |
10,511 |
11,399 |
|||
|
Equity income |
(88) |
(9,627) |
|||
|
Facility closures, severance and related costs |
158 |
2,411 |
|||
|
Antitrust costs |
3,166 |
4,053 |
|||
|
Operating profit |
65,917 |
16,084 |
|||
|
Interest expense |
24,406 |
17,925 |
|||
|
Other (income) expense, net |
8,799 |
(92,754) |
|||
|
Earnings from continuing operations before |
|||||
|
income taxes |
32,712 |
90,913 |
|||
|
Income tax expense |
14,483 |
30,120 |
|||
|
Earnings from continuing operations |
18,229 |
60,793 |
|||
|
Earnings from discontinued operations |
2,206 |
160 |
|||
|
Net earnings |
$ |
20,435 |
$ |
60,953 |
|
|
Basic earnings per common share: |
|||||
|
Earnings from continuing operations |
$ |
0.16 |
$ |
0.53 |
|
|
Earnings from discontinued operations |
0.02 |
- |
|||
|
Net earnings |
$ |
0.18 |
$ |
0.53 |
|
|
Diluted earnings per common share: |
|||||
|
Earnings from continuing operations |
$ |
0.15 |
$ |
0.53 |
|
|
Earnings from discontinued operations |
0.02 |
- |
|||
|
Net earnings |
$ |
0.17 |
$ |
0.53 |
|
|
Dividends per common share |
$ |
0.05 |
$ |
0.05 |
|
|
See accompanying notes to condensed consolidated financial statements. |
|||||
-2-
CROMPTON CORPORATION AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
March 31, 2005 (Unaudited) and December 31, 2004
(In thousands of dollars)
|
March 31, |
December 31, |
|||
|
2005 |
2004 |
|||
|
ASSETS |
||||
|
CURRENT ASSETS |
||||
|
Cash and cash equivalents |
$ |
118,411 |
$ |
158,700 |
|
Accounts receivable |
267,106 |
242,435 |
||
|
Inventories |
404,093 |
383,635 |
||
|
Other current assets |
153,254 |
165,554 |
||
|
Assets held for sale |
95,877 |
97,252 |
||
|
Total current assets |
1,038,741 |
1,047,576 |
||
|
NON-CURRENT ASSETS |
||||
|
Property, plant and equipment |
674,137 |
694,925 |
||
|
Cost in excess of acquired net assets |
401,288 |
407,975 |
||
|
Other assets |
525,823 |
528,233 |
||
|
$ |
2,639,989 |
$ |
2,678,709 |
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
||||
|
CURRENT LIABILITIES |
||||
|
Short-term borrowings |
$ |
14,137 |
$ |
4,294 |
|
Accounts payable |
207,593 |
231,473 |
||
|
Accrued expenses |
307,460 |
338,709 |
||
|
Income taxes payable |
99,916 |
107,686 |
||
|
Other current liabilities |
21,265 |
23,555 |
||
|
Liabilities held for sale |
3,866 |
3,452 |
||
|
Total current liabilities |
654,237 |
709,169 |
||
|
NON-CURRENT LIABILITIES |
||||
|
Long-term debt |
877,927 |
862,251 |
||
|
Pension and post-retirement health care liabilities |
557,595 |
566,759 |
||
|
Other liabilities |
214,951 |
211,550 |
||
|
STOCKHOLDERS' EQUITY |
||||
|
Common stock |
1,192 |
1,192 |
||
|
Additional paid-in capital |
1,033,291 |
1,032,282 |
||
|
Accumulated deficit |
(633,051) |
(647,678) |
||
|
Accumulated other comprehensive loss |
(49,651) |
(22,372) |
||
|
Treasury stock at cost |
(16,502) |
(34,444) |
||
|
Total stockholders' equity |
335,279 |
328,980 |
||
|
$ |
2,639,989 |
$ |
2,678,709 |
|
|
See accompanying notes to condensed consolidated financial statements. |
||||
-3-
CROMPTON CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows (Unaudited)
First quarter ended March 31, 2005 and 2004
(In thousands of dollars)
|
Increase (decrease) in cash |
2005 |
2004 |
||||
|
CASH FLOWS FROM OPERATING ACTIVITIES |
||||||
|
Net earnings |
$ |
20,435 |
$ |
60,953 |
||
|
Adjustments to reconcile net earnings to net |
||||||
|
cash used in operations: |
||||||
|
Gain on sale of Gustafson joint venture |
- |
(90,938) |
||||
|
Depreciation and amortization |
32,135 |
30,854 |
||||
|
Equity income |
(88) |
(9,627) |
||||
|
Changes in assets and liabilities, net: |
||||||
|
Accounts receivable |
(40,606) |
(42,642) |
||||
|
Accounts receivable - securitization |
1,596 |
(20,333) |
||||
|
Inventories |
(30,168) |
(4,475) |
||||
|
Accounts payable |
(20,490) |
(1,807) |
||||
|
Other |
(32,834) |
15,768 |
||||
|
Net cash used in operations |
(70,020) |
(62,247) |
||||
|
CASH FLOWS FROM INVESTING ACTIVITIES |
||||||
|
Net proceeds from divestments |
11,797 |
129,516 |
||||
|
Capital expenditures |
(13,978) |
(16,640) |
||||
|
Other investing activities |
(28) |
391 |
||||
|
Net cash (used in) provided by investing activities |
(2,209) |
113,267 |
||||
|
CASH FLOWS FROM FINANCING ACTIVITIES |
||||||
|
Proceeds from (payments on) domestic credit facility |
25,000 |
(49,400) |
||||
|
(Payments on) proceeds from short-term borrowings |
(162) |
727 |
||||
|
Dividends paid |
(5,808) |
(5,727) |
||||
|
Proceeds from exercise of stock options |
13,333 |
4 |
||||
|
Other financing activities |
991 |
167 |
||||
|
Net cash provided by (used in) financing activities |
33,354 |
(54,229) |
||||
|
CASH |
||||||
|
Effect of exchange rates on cash |
(1,414) |
(138) |
||||
|
Change in cash |
(40,289) |
(3,347) |
||||
|
Cash at beginning of period |
158,700 |
39,213 |
||||
|
Cash at end of period |
$ |
118,411 |
$ |
35,866 |
||
|
See accompanying notes to condensed consolidated financial statements. |
||||||
-4-
CROMPTON CORPORATION AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (Unaudited)
ACCOUNTING POLICIES
Presentation of Condensed Consolidated Financial Statements
The information in the foregoing condensed consolidated financial statements for the first quarter ended March 31, 2005 and March 31, 2004 is unaudited, but reflects all adjustments that are of a normal recurring nature, which in the opinion of management, are necessary for a fair presentation of the results of operations for the interim periods presented. The foregoing condensed consolidated financial statements include the accounts of Crompton Corporation and its wholly-owned and majority owned subsidiaries, which are collectively referred to as "the Company." Other affiliates in which the Company has a 20% to 50% ownership are accounted for in accordance with the equity method.
As a result of the agreement to sell the Refined Products business to Sun Capital Partners Group, Inc. announced on March 18, 2005, the accompanying condensed consolidated financial statements reflect the Refined Products business as a discontinued operation. The operations of the Refined Products business have been classified as earnings from discontinued operations (net of tax) and the estimated carrying amount of the assets being sold and of the liabilities being transferred have been reflected as assets and liabilities held for sale for all periods presented. The condensed consolidated statements of cash flows have not been adjusted to reflect the discontinued operation and thus include the cash flows of the Refined Products business for all periods presented. Refer to the discontinued operations footnote for further information.
Certain financial information and footnote disclosures included in the annual financial statements have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission for reporting on Form 10-Q. The interim consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company's 2004 Annual Report on Form 10-K. The consolidated results of operations for the three months ended March 31, 2005 are not necessarily indicative of the results expected for the full year.
Operating Costs and Expenses
Cost of products sold includes all costs incurred in manufacturing products, including raw materials, direct manufacturing costs and manufacturing overhead. Cost of products sold also includes warehousing, distribution, engineering (other than polymer processing equipment design engineering), purchasing, customer service and environmental, health and safety functions, and shipping costs for outbound product shipments. Selling, general and administrative expenses (SG&A) include costs and expenses related to the following functions and activities: selling, advertising, polymer processing equipment design engineering, information technology, legal, provision for doubtful accounts, corporate facilities and corporate administration. SG&A also includes accounting, finance and human resources, excluding direct support in manufacturing operations, which is included as cost of products sold. Research and development expenses (R&D) include basic and applied research and development activities of a technical and non-routine nature. R&D costs are expensed as incurred. Costs of products sold, SG&A and R&D expenses exclude depreciation and amortization expenses, which are presented on a separate line in the condensed consolidated statements of earnings.
Included in cost of products sold are shipping costs of $15.7 million and $16.7 million for the first quarters ended March 31, 2005 and March 31, 2004, respectively.
Other
Included in the Company's condensed consolidated balance sheets at March 31, 2005 and December 31, 2004, is approximately $15 million and $20 million, respectively, of restricted cash that is required to be on deposit to support certain letters of credit and performance guarantees, the majority of which will be settled within one year. In addition, at March 31, 2005, the Company had approximately $58.2 million in a cash collateral account that is restricted to pay current and future litigation liabilities, including related legal costs.
Included in accounts receivable are allowances for doubtful accounts of $22.6 million at March 31, 2005 and $22.3 million at December 31, 2004.
Accumulated depreciation amounted to $854.3 million at March 31, 2005 and $835.6 million at December 31, 2004.
RECLASSIFICATIONS
Certain reclassifications have been made to the prior year condensed consolidated statement of earnings, including the reclassification of shipping costs from SG&A to cost of products sold to provide comparability to other entities in the Company's business sector.
-5-
STOCK-BASED COMPENSATION
As permitted under Financial Accounting Standards Board (FASB) Statements No. 123, "Accounting for Stock-Based Compensation" and No. 148, "Accounting for Stock-Based Compensation - Transition and Disclosure," the Company elected to continue its historical method of accounting for stock-based compensation in accordance with Accounting Principles Board Opinion (APB) No. 25, "Accounting for Stock Issued to Employees." Under APB 25, compensation expense for fixed plans is recognized based on the difference between the exercise price and the stock price on the date of grant. Since the Company's fixed plan awards have been granted with an exercise price equal to the stock price on the date of grant, no compensation expense has been recognized in the statement of operations for these awards. However, compensation expense has been recognized for the restricted stock awards under the Company's long-term incentive programs in accordance with the provisions of APB 25, which would be unchanged under FASB Statements No. 123 and No. 148. In December 2004, the FASB issued Statement No. 123 (revised 2004), "Share-Based Payment", which replaces FASB Statement No. 123 and supercedes APB Opinion No. 25. FASB Statement No. 123 (revised 2004) requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair value, beginning with the first interim period after June 15, 2005. On April 14, 2005, the Securities and Exchange Commission announced that the effective date of Statement No. 123 (revised 2004) will be suspended until the beginning of the first fiscal year beginning after June 15, 2005. The Company is in the process of reviewing the accounting impact of these awards under FASB Statement No. 123 (revised 2004).
The following table illustrates the effect on net earnings (loss) and related per share amounts as if the Company had applied the fair value recognition provisions of Statements No. 123 and No. 148 to all stock-based employee compensation awards.
|
First quarter ended |
||||
|
(In thousands, except per share data) |
2005 |
2004 |
||
|
Net earnings, as reported |
$ |
20,435 |
$ |
60,953 |
|
Stock-based employee compensation expense |
||||
|
included in net earnings, net of tax |
872 |
314 |
||
|
Total stock-based employee compensation determined under |
|
|||
|
fair value based accounting method for all awards, net of tax |
(2,212) |
(1,187) |
||
|
Pro forma net earnings |
$ |
19,095 |
$ |
60,080 |
|
Basic earnings per share: |
||||
|
Basic - as reported |
$ |
0.18 |
$ |
0.53 |
|
Basic - pro forma |
$ |
0.16 |
$ |
0.52 |
|
Diluted earnings per share: |
||||
|
Diluted - as reported |
$ |
0.17 |
$ |
0.53 |
|
Diluted - pro forma |
$ |
0.16 |
$ |
0.52 |
FACILITY CLOSURES, SEVERANCE AND RELATED COSTS
During the first quarter of 2004, the Company appointed a new President and CEO, and the former Chairman, President and CEO; Senior Vice President and CFO; and certain other executives elected to retire. As a result of this reorganization, the Company completed the separation agreements for the former Chairman, President and CEO, Senior Vice President and CFO, and other executives and recorded a pre-tax charge of $2.8 million for severance and related costs in 2004. During the first quarter of 2005, the Company reversed $0.2 million of the 2004 charge to adjust for reserves no longer deemed necessary. Payments and non-cash activity related to this charge were $1.1 million during 2004 and $0.4 million during the first quarter of 2005. The remaining reserve balance at March 31, 2005 was $1.1 million.
In 2004, the Company completed an activity-based restructuring initiative, including a voluntary severance program, intended to structure the Company's operations in a more efficient and cost effective manner. As a result of the voluntary program, 137 U.S. based employees voluntarily elected to terminate their employment. In addition, the Company is in the process of involuntarily terminating approximately 500 worldwide employees as a result of the activity-based restructuring initiative, of which approximately 439 have been terminated as of March 31, 2005. During 2004, the Company recorded pre-tax charges of $54 million for facility closures, severance and related costs. The Company recorded additional charges during the first quarter of 2005 of $2.3 million. The related reserve activity is as follows:
-6-
|
(In thousands) |
Severance |
Asset |
Other |
Total |
||||
|
2004 charge: |
|
|
|
|
||||
|
Continuing operations |
$ |
50,556 |
$ |
138 |
$ |
3,030 |
$ |
53,724 |
|
Discontinued operations |
306 |
- |
- |
306 |
||||
|
Cash payments |
(9,061) |
- |
(1,439) |
(10,500) |
||||
|
Non-cash charges |
(1,748) |
(138) |
- |
(1,886) |
||||
|
Balance at December 31, 2004 |
|
40,053 |
- |
1,591 |
|
41,644 |
||
|
2005 charge |
1,914 |
- |
391 |
2,305 |
||||
|
Cash payments |
(14,412) |
- |
(723) |
(15,135) |
||||
|
Non-cash charges |
84 |
- |
- |
84 |
||||
|
Balance at March 31, 2005 |
$ |
27,639 |
$ |
- |
$ |
1,259 |
$ |
28,898 |
During the fourth quarter of 2004, the Enenco joint venture, in which the Company owned a 50 percent interest, closed its manufacturing facility in Memphis, TN. As a result of the closure, the Company recorded a pre-tax charge of $4.6 million to facility closures, severance and related costs, which included $2.3 million related to the write-off of the Company's investment in affiliate, $1.8 million for environmental decommissioning and demolition costs and $0.5 million for other closure related costs. During the first quarter of 2005, the Company obtained the remaining 50 percent interest from its joint venture partner and as a result has accounted for Enenco as a wholly-owned subsidiary of the Company. This transaction resulted in a pre-tax credit to facility closures, severance and related costs of $2 million primarily due to recoveries from the joint venture partner of $1.1 million, adjustments to third party accruals of $0.7 million and adjustments to decommissioning and demolition reserves of $0 .2 million.
In July 2003, the Company announced a cost reduction program to eliminate, at a minimum, overhead expenses previously absorbed by the OrganoSilicones business. The related reserve activity is as follows:
|
(In thousands) |
Severance |
Other |
Total |
|||
|
Balance at December 31, 2003 |
$ |
9,726 |
$ |
605 |
$ |
10,331 |
|
2004 charge |
558 |
7 |
565 |
|||
|
Cash payments |
(8,596) |
(529) |
(9,125) |
|||
|
Balance at December 31, 2004 |
1,688 |
83 |
|
1,771 |
||
|
2005 reserve adjustment |
(30) |
- |
(30) |
|||
|
Cash payments |
(317) |
- |
(317) |
|||
|
Balance at March 31, 2005 |
$ |
1,341 |
$ |
83 |
$ |
1,424 |
As a result of the cost reduction initiative that began in 2001 and the relocation of the Company's headquarters from Greenwich, CT to Middlebury, CT that began in 2002, the Company recorded pre-tax charges for facility closures, severance and related costs. The related reserve activity is summarized as follows:
-7-
|
(In thousands) |
Severance |
Asset |
Other |
Total |
||||
|
Balance at December 31, 2003 |
$ |
8,392 |
$ |
- |
$ |
4,075 |
$ |
12,467 |
|
2004 charge |
(1,492) |
559 |
14 |
(919) |
||||
|
Cash payments |
(5,474) |
- |
(2,537) |
(8,011) |
||||
|
Non-cash charges |
(370) |
(559) |
- |
(929) |
||||
|
Balance at December 31, 2004 |
1,056 |
- |
|
1,552 |
|
2,608 |
||
|
2005 charge |
(6) |
- |
51 |
45 |
||||
|
Cash |